402 POSTER A phase I study of gemcitabine, capecitabine and vandetanib in patients with advanced solid tumors with an expanded cohort in biliary and pancreatic malignancies

S.Leong; C.L.Obryant; W.A.Messersmith; S.Diab; M.A.Kane; S.Nallapreddy; C.Weekes; J.Spratlin; J.Call; S.G.Eckhardt

首页> 外文期刊>European Journal of Cancer Supplements >402 POSTER A phase I study of gemcitabine, capecitabine and vandetanib in patients with advanced solid tumors with an expanded cohort in biliary and pancreatic malignancies

【24h】

402 POSTER A phase I study of gemcitabine, capecitabine and vandetanib in patients with advanced solid tumors with an expanded cohort in biliary and pancreatic malignancies

机译：402事后吉西他滨，卡培他滨和凡德他尼在胆汁和胰腺恶性肿瘤队列扩大的晚期实体瘤患者中的I期研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2008年第12期|共1页
作者
S.Leong; C.L.Obryant; W.A.Messersmith; S.Diab; M.A.Kane; S.Nallapreddy; C.Weekes; J.Spratlin; J.Call; S.G.Eckhardt;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 402 POSTER A phase I study of gemcitabine, capecitabine and vandetanib in patients with advanced solid tumors with an expanded cohort in biliary and pancreatic malignancies [J] . S.Leong, C.L.Obryant, W.A.Messersmith, European Journal of Cancer Supplements . 2008,第12期

机译：402事后吉西他滨，卡培他滨和凡德他尼在胆汁和胰腺恶性肿瘤队列扩大的晚期实体瘤患者中的I期研究
2. Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers [J] . Kessler Elizabeth R., Eckhardt S. Gail, Pitts Todd M., Investigational new drugs. . 2016,第2期

机译：凡德他尼联合吉西他滨和卡培他滨用于胰腺癌和胆道癌晚期实体瘤合并队列研究的第一阶段试验
3. A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients [J] . Wen Wee Ma, Hao Xie, Gerald Fetterly, American Journal of Clinical Oncology: Cancer Clinical Trials . 2019,第2期

机译：FGFR / VEGFR抑制剂DOVITINIB与吉西他滨和Capecitabine在先进的实体瘤和胰腺癌患者中的一期IB研究
4. Tumor Vessel Destruction Resulting from High-intensity FocusedUltrasound in Patients with Solid Malignancies [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：实体恶性肿瘤患者高强度聚焦超声引起的肿瘤血管破坏
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers [O] . Elizabeth R Kessler, S Gail Eckhardt, Todd M Pitts, -1

机译：凡德他尼联合吉西他滨和卡培他滨用于胰腺癌和胆道癌的晚期实体瘤合并队列研究的第一阶段试验
7. Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers [O] . Elizabeth R. Kessler, S. Gail Eckhardt, Todd M. Pitts, 2015

机译：Vandetanib的阶段与吉西他滨和Capecitabine相结合的先进实体瘤的患者，胰腺和胆道癌症中的扩张队列

402 POSTER A phase I study of gemcitabine, capecitabine and vandetanib in patients with advanced solid tumors with an expanded cohort in biliary and pancreatic malignancies

著录项

相似文献

相关主题

期刊订阅